| 1031 Secondary primary malignancy risk among in patients with ovarian cancer in Taiwan: A nationwide population-based study YP Hung, CJ Liu, YW Hu, CM Yeh, MH Chen, CP Li, TJ Chiou, TJ Chen, ... European Journal of Cancer 3 (51), S155, 2015 | 1 | 2015 |
| 187P Phase I/II study of the oral CCR4 antagonist, FLX475, as monotherapy and in combination with pembrolizumab in advanced cancer CC Lin, TM Kim, P Desai, KH Lee, YH Feng, N Ngamphaiboon, SB Kim, ... Immuno-Oncology and Technology 16, 2022 | | 2022 |
| 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia. MH Yang, CH Ho Zhonghua yi xue za zhi= Chinese Medical Journal; Free China ed 64 (1), 54-58, 2001 | 3 | 2001 |
| 2‐Methoxyestradiol attenuates phosphatidylinositol 3‐kinase/Akt pathway‐mediated metastasis of gastric cancer HL Lin, MH Yang, CW Wu, PM Chen, YP Yang, YR Chu, CL Kao, HH Ku, ... International journal of cancer 121 (11), 2547-2555, 2007 | 52 | 2007 |
| 212 Results of single arm, multi-center, two-stage phase II clinical study of thalidomide in Taiwanese patients with myelodysplastic syndrome (MDS) CS Chang, TJ Chiou, SF Lin, PM Chen, MC Chang, WY Kao, TY Chao, ... Leukemia Research, S83, 2011 | | 2011 |
| 5Department of Surgery, Taipei-Veterans General Hospital, No. 201, Section 2, Shipai Road, Beitou YFT Jeng, MH Yang, WW Hwang-Verslues | | |
| 652O Randomized phase III VANCE study: Gemcitabine and carboplatin (GC) followed by Epstein Barr virus-specific autologous cytotoxic T lymphocytes (EBV-CTL) versus the same … HC Toh, MH Yang, HM Wang, CY Hsieh, I Chitapanarux, KF Ho, RL Hong, ... Annals of Oncology 33, S840, 2022 | 5 | 2022 |
| A Clinical Recommendation for Defining Platinum-Unsuitable Patients With Head and Neck Cancer: A Taiwan Experience CH Wang, MH Yang, CJ Yen, PJ Lou, HM Wang, SP Hao, MK Chen, ... International Journal of Head and Neck Science 5 (2), 41-54, 2021 | | 2021 |
| A CSF-1R-blocking antibody/IL-10 fusion protein increases anti-tumor immunity by effectuating tumor-resident CD8+ T cells YW Chang, HW Hsiao, JP Chen, SF Tzeng, CH Tsai, CY Wu, HH Hsieh, ... Cell Reports Medicine 4 (8), 2023 | 2 | 2023 |
| A generational comparison for unfavorable cancer of unknown primary in a single institute over 20 years CY Tang, JF Hang, YP Hung, NC Chiu, JI Lai, MH Chen, CY Liu, ... Cancer Medicine 12 (2), 1090-1101, 2023 | | 2023 |
| A nation-wide analysis of venous thromboembolism in 497 180 cancer patients with the development and validation of a risk-stratification scoring system YB Yu, JP Gau, CY Liu, MH Yang, SC Chiang, HC Hsu, YC Hong, ... JOURNAL OF THROMBOSIS AND HAEMOSTASIS 9, 638-639, 2011 | | 2011 |
| A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system YB Yu, JP Gau, CY Liu, MH Yang, SC Chiang, HC Hsu, YC Hong, ... Thrombosis and haemostasis 108 (08), 225-235, 2012 | 107 | 2012 |
| A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or … LY Bai, MH Yang, NJ Chiang, SY Wu, CY Lin, MY Lien, JH Chen, ... Journal of Clinical Oncology 39 (15_suppl), 6025-6025, 2021 | 5 | 2021 |
| A phase Ib/II study of GFH018 in combination with toripalimab in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC). HQ Mai, Y Guo, MH Yang, K Yang, LT Chen, H Mun, Y Yang, S Wang, ... Journal of Clinical Oncology 41 (16_suppl), 6026-6026, 2023 | 2 | 2023 |
| A positive feedback loop between Snail and TNF-alpha promote tumor invasiveness through acetylation of Snail DSS Hsu, HJ Wang, MH Yang INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 32, S11-S11, 2013 | | 2013 |
| A rare complication of acquired factor VIII inhibitors in a postoperative oral cancer patient: a case report YW Chen, MH Yang, SY Kao, CH Wu Journal of oral and maxillofacial surgery 68 (8), 1989-1993, 2010 | 5 | 2010 |
| A real-world study of prognostic factors and risk-stratification model from Taiwanese patients with recurrent or metastatic head and neck squamous cell carcinoma treated with … MH Yang, C Tien Hua, MC Hsieh, HC Huang, CY Chien, TL Huang, ... Journal of Clinical Oncology 40 (16_suppl), e18013-e18013, 2022 | | 2022 |
| A regulatory BMI 1/let‐7i/ERK 3 pathway controls the motility of head and neck cancer cells L Elkhadragy, M Chen, K Miller, MH Yang, W Long Molecular oncology 11 (2), 194-207, 2017 | 40 | 2017 |
| A study using ifosfamide and etoposide in patients with cisplatin-refractory recurrent or metastatic head and neck squamous cell carcinoma YC Huang, PMH Chang, MH Chen, PY Chu, CH Tzeng, SY Chang, ... Japanese journal of clinical oncology 41 (5), 630-636, 2011 | 7 | 2011 |
| A two-dimensional immunomagnetic nano-net for the efficient isolation of circulating tumor cells in whole blood CH Lai, WS Tsai, MH Yang, TY Chou, YC Chang Nanoscale 11 (44), 21119-21127, 2019 | 20 | 2019 |
